.png){kind=icon}
.png){kind=icon}
Return
High-throughput quantification of tacrolimus in whole blood by acoustic ejection mass spectrometry: analytical validation and comparative assessment against conventional LC-MS/MS for therapeutic drug monitoring
.png){kind=icon}
PRE
AI
X
X
A
W
H
N
S
Y
DOI：10.1016/j.cca.2026.120986.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Background: Therapeutic drug monitoring (TDM) of tacrolimus requires accurate, high-throughput methods, but conventional liquid chromatography-tandem mass spectrometry (LC-MS/MS) is limited by lengthy run times and complex sample preparation. Methods: We developed a chromatography-free assay for quantification of tacrolimus in whole blood by integrating cold-induced phase separation with acoustic ejection mass spectrometry (AEMS). This workflow only requires less than 10 & micro;L of whole blood, eliminates centrifugation, and enables direct nanoliter-scale injection into the mass spectrometer. The AEMS assay performance was validated in accordance with CLSI C62-A and ICH M10 guidelines using 62 patient samples and matrix-matched calibrators, demonstrating its suitability for high-throughput therapeutic drug monitoring. Results: The AEMS assay exhibited excellent linearity (0.5-50 & micro;g/L; R2 = 0.9987), with a lower limit of quantification of 0.5 & micro;g/L, which was well below clinically relevant trough concentrations. Accuracy (93.3%-100.1%) and precision (intra-day RSD: 3.7%-11.3%; inter-day RSD: 2.3%-12.4%) met regulatory acceptance criteria. Results showed strong concordance with routine LC-MS/MS (Spearman rho = 0.972; Passing-Bablok slope = 1.100 [95% CI: 1.026-1.177]). The total analysis cycle time was less than 3 s per sample, enabling a throughput exceeding 1000 samples per hour theoretically. Conclusion: This study establishes the first chromatography-free mass spectrometry platform validated for clinical TDM of TAC. By integrating ultra-high throughput capability, minimal sample consumption, and robust analytical performance, the AEMS workflow offers a transformative analytical solution for high-demand clinical environments, including transplant centers and pediatric monitoring settings.
Keywords:
Tacrolimus
AEMS
High throughput
Therapeutic drug monitoring
Journal
IF:
2.9
Papers:
1.5W
Citations:
2.1W
Organization
Cited Papers